However, other clinicopathological features (including gender, age, tumor location, Lauren type, differentiation type, and LI) are not associated with overexpression of CD133 (all P > 0.05) (Figs. 2–4 and Table 2). The gene discussed is PROM1; the disease is neoplasm.